• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Clorox Releases its FY23 Integrated Annual Report Highlighting Progress Against its IGNITE Strategy and ESG Goals

    10/6/23 9:00:00 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary
    Get the next $CLX alert in real time by email

    OAKLAND, Calif., Oct. 6, 2023 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today released its fiscal year 2023 integrated annual report, showcasing performance and progress against its IGNITE strategy in driving transformation, growth and long-term shareholder value, all aligned with its purpose and values.

    The Clorox Company 2023 Integrated Annual Report

    The Clorox Company today released its fiscal year 2023 integrated annual report, showcasing performance and progress.

    Highlighting the company's 110th year of business and operational performance, the report details how the company generated record-high revenue and maintained total company market share through IGNITE and its integrated environmental, social and governance, or ESG, goals. Highlights include:

    • Fuel Growth: Delivering cost savings above the IGNITE goal of 175 basis point EBIT margin accretion, helping to rebuild margin back to pre-pandemic levels, and integrating strategic choices, such as reducing plastic and other waste, to drive cost savings and sustainability goals.
    • Innovate Experiences: Launching innovations, many of which have environmental sustainability attributes, across all major brands and hitting all-time high return on marketing investments.
    • Reimagine Work: Investing in the company's digital transformation and new operating model to create a more inclusive, consumer-obsessed, faster and leaner company.
    • Evolve the Portfolio: Maintaining a portfolio with 60% of its brands deemed superior value, a testament to strong, trusted brands and the commitment to meet the diverse needs of today's consumers.
    • Sustainability: Achieving 88% of the 2025 circular economy goal for 100% recyclable, reusable or compostable packaging and maintaining 100% electricity from renewable energy for U.S. and Canada operations, which helped accomplish its 2030 scopes 1 and 2 science-based target. Advancing product stewardship and employee wellbeing efforts to support healthier lives.

    "Our integrated annual report reflects our journey toward a stronger, more resilient future where we champion people to be well and thrive every single day," said Clorox CEO Linda Rendle. "We are proud of the progress we've made through our IGNITE strategy and are optimistic about the opportunities ahead. This report is a testament to our teammates around the globe who delivered our strong fiscal year 2023 performance and our continued commitment to our stakeholders and our planet."

    The full version of the integrated annual report, available as an interactive PDF online at thecloroxcompany.com/annualreport, includes a graphic documenting the company's value creation process, financial statements, an ESG materiality overview, and ESG reporting against Sustainability Accounting Standards Board's standards, and the Task Force on Climate-Related Financial Disclosures. It also documents how the company's ESG priorities support the U.N. Sustainable Development Goals. An executive summary of the report is published online in English and Spanish as well.

    About The Clorox Company

    The Clorox Company (NYSE:CLX) champions people to be well and thrive every single day. Its trusted brands, which include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr®, Pine-Sol® and Natural Vitality®, can be found in about nine of 10 U.S. homes and internationally with brands such as Ayudin®, Clorinda®, Chux® and Poett®. Headquartered in Oakland, California, since 1913, Clorox was one of the first U.S. companies to integrate ESG into its business reporting. Visit thecloroxcompany.com to learn more.

    CLX-C

    Forward-Looking Statements

    This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, among others, statements regarding the expected or potential impact of the company's operational disruption stemming from a cybersecurity attack, and any such forward-looking statements involve risks, assumptions and uncertainties. Except for historical information, statements about future volumes, sales, organic sales growth, foreign currencies, costs, cost savings, margins, earnings, earnings per share, diluted earnings per share, foreign currency exchange rates, tax rates, cash flows, plans, objectives, expectations, growth or profitability are forward-looking statements based on management's estimates, beliefs, assumptions and projections. Words such as "could," "may," "expects," "anticipates," "targets," "goals," "projects," "intends," "plans," "believes," "seeks," "estimates," "will," "predicts," and variations on such words, and similar expressions that reflect our current views with respect to future events and operational, economic and financial performance are intended to identify such forward-looking statements. These forward-looking statements are only predictions, subject to risks and uncertainties, and actual results could differ materially from those discussed. Important factors that could affect performance and cause results to differ materially from management's expectations, are described in the sections entitled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the company's Annual Report on Form 10-K for the fiscal year ended June 30, 2023, as updated from time to time in the company's Securities and Exchange Commission filings. These factors include, but are not limited to: unfavorable general economic and geopolitical conditions beyond our control, including supply chain disruptions, labor shortages, wage pressures, rising inflation, fuel and energy costs, foreign currency exchange rate fluctuations, weather events or natural disasters, disease outbreaks or pandemics, such as COVID-19, terrorism, and unstable geopolitical conditions, including the conflict in Ukraine, as well as macroeconomic and geopolitical volatility and uncertainty as a result of a number of these and other factors, including rising tensions between China and Taiwan and actual and potential shifts between the U.S. and its trading partners, especially China; volatility and increases in the costs of raw materials, energy, transportation, labor and other necessary supplies or services; the impact of the changing retail environment, including the growth of alternative retail channels and business models, and changing consumer preferences; the ability of the company to drive sales growth, increase prices and market share, grow its product categories and manage favorable product and geographic mix; risks related to supply chain issues, product shortages and disruptions to the business, as a result of increased supply chain dependencies due to an expanded supplier network and a reliance on certain single-source suppliers; intense competition in the company's markets; risks related to the company's use of and reliance on information technology systems, including potential and actual security breaches, cyber-attacks, privacy breaches or data breaches that result in the unauthorized disclosure of consumer, customer, employee or company information, business, service or operational disruptions, or that impact the company's financial results or financial reporting, or any resulting unfavorable outcomes, increased costs or legal proceedings; the ability of the company to implement and generate cost savings and efficiencies, and successfully implement its transformational initiatives or strategies, including achieving anticipated benefits and cost savings from the implementation of the streamlined operating model and digital capabilities and productivity enhancements; dependence on key customers and risks related to customer consolidation and ordering patterns; the company's ability to attract and retain key personnel, which may continue to be impacted by challenges in the labor market, such as wage inflation and sustained labor shortages; the company's ability to maintain its business reputation and the reputation of its brands and products; lower revenue, increased costs or reputational harm resulting from government actions and compliance with regulations, or any material costs imposed by changes in regulation; changes to our processes and procedures as a result of our digital capabilities and productivity enhancements investment that may result in changes to the company's internal controls over financial reporting; the ability of the company to successfully manage global political, legal, tax and regulatory risks, including changes in regulatory or administrative activity; risks related to international operations and international trade, including changing macroeconomic conditions as a result of inflation, volatile commodity prices and increases in raw and packaging materials prices, labor, energy and logistics; global economic or political instability; foreign currency fluctuations, such as devaluations, and foreign currency exchange rate controls; changes in governmental policies, including trade, travel or immigration restrictions, new or additional tariffs, and price or other controls; labor claims and civil unrest; continued high levels of inflation in Argentina; potential operational or supply chain disruptions from wars and military conflicts, including the conflict in Ukraine; impact of the United Kingdom's exit from the European Union; potential negative impact and liabilities from the use, storage and transportation of chlorine in certain international markets where chlorine is used in the production of bleach; widespread health emergencies, such as COVID-19; and the possibility of nationalization, expropriation of assets or other government action; the impact of Environmental, Social, and Governance (ESG) issues, including those related to climate change and sustainability on our sales, operating costs or reputation; the ability of the company to innovate and to develop and introduce commercially successful products, or expand into adjacent categories and countries; the impact of product liability claims, labor claims and other legal, governmental or tax proceedings, including in foreign jurisdictions and in connection with any product recalls; the COVID-19 pandemic and related impacts, including on the availability of, and efficiency of the supply, manufacturing and distribution systems for, the company's products, including any significant disruption to such systems; on the demand for and sales of the company's products; and on worldwide, regional and local adverse economic conditions; risks relating to acquisitions, new ventures and divestitures, and associated costs, including for asset impairment charges related to, among others, intangible assets, including trademarks and goodwill, in particular the impairment charges related to the carrying value of the company's Vitamins, Minerals and Supplements business; and the ability to complete announced transactions and, if completed, integration costs and potential contingent liabilities related to those transactions; the accuracy of the company's estimates and assumptions on which its financial projections, including any sales or earnings guidance or outlook it may provide from time to time, are based; risks related to increases in the estimated fair value of The Procter & Gamble Company's interest in the Glad business; environmental matters, including costs associated with the remediation and monitoring of past contamination, and possible increases in costs resulting from actions by relevant regulators, and the handling and/or transportation of hazardous substances;  the company's ability to effectively utilize, assert and defend its intellectual property rights, and any infringement or claimed infringement by the company of third-party intellectual property rights; the performance of strategic alliances and other business relationships; the effect of the company's indebtedness and credit rating on its business operations and financial results and the company's ability to access capital markets and other funding sources, as well as the cost of capital to the company; the company's ability to pay and declare dividends or repurchase its stock in the future; the impacts of potential stockholder activism; and risks related to any litigation associated with the exclusive forum provision in the company's bylaws.

    The company's forward-looking statements in this press release are based on management's current views, beliefs, assumptions and expectations regarding future events and speak only as of the date of this press release. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the federal securities laws.

    (PRNewsfoto/The Clorox Company)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/clorox-releases-its-fy23-integrated-annual-report-highlighting-progress-against-its-ignite-strategy-and-esg-goals-301949164.html

    SOURCE The Clorox Company

    Get the next $CLX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLX

    DatePrice TargetRatingAnalyst
    2/11/2026Underperform → Neutral
    BNP Paribas Exane
    10/1/2025$118.00 → $112.00Underweight
    Barclays
    1/7/2025$157.00Underweight → Equal Weight
    Wells Fargo
    11/6/2024$155.00 → $170.00Sell → Hold
    TD Cowen
    10/1/2024$174.00 → $187.00Hold → Buy
    Jefferies
    7/23/2024$122.00Sell
    TD Cowen
    6/24/2024$130.00Underperform
    Exane BNP Paribas
    4/2/2024$170.00 → $165.00Buy → Neutral
    Citigroup
    More analyst ratings

    $CLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Clorox upgraded by BNP Paribas Exane

    BNP Paribas Exane upgraded Clorox from Underperform to Neutral

    2/11/26 8:53:35 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Barclays reiterated coverage on Clorox with a new price target

    Barclays reiterated coverage of Clorox with a rating of Underweight and set a new price target of $112.00 from $118.00 previously

    10/1/25 10:49:28 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Clorox from Underweight to Equal Weight and set a new price target of $157.00

    1/7/25 7:46:13 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $CLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $CLX
    SEC Filings

    View All

    $CLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Clorox Declares Regular Quarterly Dividend of $1.24 Per Share

    OAKLAND, Calif., Feb. 24, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) announced today that its board of directors has declared a quarterly dividend of $1.24 per share on the company's common stock. The dividend is payable May 8, 2026, to shareholders of record as of the close of business on April 22, 2026.Clorox has a long history of providing value to its shareholders through regular dividend payments and annual dividend increases.About The Clorox CompanyThe Clorox Company (NYSE:CLX) champions people to be well and thrive every single day. Headquartered in Oakland, California since 1913, Clorox integrates sustainability into how it does business. Driven by consumer-centric innovation

    2/24/26 8:06:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox to Present at 2026 Citi Global Consumer & Retail Conference

    OAKLAND, Calif., Feb. 23, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced that Chief Financial Officer Luc Bellet will participate in a fireside chat at the Citi Global Consumer & Retail Conference in Miami, Florida, on Monday, Mar. 9. A live webcast of the presentation will begin at 8:45 a.m. ET (5:45 a.m. PT) and can be accessed on the company's website. A replay of the webcast will be available following the event.About The Clorox CompanyThe Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Headquartered in Oakland, California since 1913, Clorox integrates sustainability into how it does business. Driven by consumer-centric innovation,

    2/23/26 4:15:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    The Clorox Company Unveils Home Care Redefined: A Look at How Americans Are Reimagining Time, Wellness, and Convenience at Home

    Report underscores the evolution of home care from a string of chores into a meaningful source of accomplishment, satisfaction, and self‑careAwareness of the home's influence on family health is rising, and younger generations are taking a more proactive, wellness‑focused approach to home careConvenience is being reimagined: consumers now value ease and enjoyment over sheer speed in their everyday routinesOAKLAND, Calif., Feb. 19, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced the release of Home Care Redefined, a first-of-its-kind report designed to define the evolving landscape of consumer home care. Drawing on extensive consumer research and insights, the report detail

    2/19/26 9:00:00 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 4 filed by Director Williams Christopher J

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    1/5/26 4:50:10 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 4 filed by Director Weiner Russell J

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    1/5/26 4:49:10 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 4 filed by Director Plaines Stephanie

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    1/5/26 4:47:53 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form 10-Q filed by Clorox Company

    10-Q - CLOROX CO /DE/ (0000021076) (Filer)

    2/3/26 4:45:17 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Company filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CLOROX CO /DE/ (0000021076) (Filer)

    2/3/26 4:11:43 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Company filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - CLOROX CO /DE/ (0000021076) (Filer)

    1/22/26 4:11:47 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Director Breber Pierre R bought $416,516 worth of shares (4,000 units at $104.13) (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    11/24/25 4:37:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Director Breber Pierre R bought $546,285 worth of shares (4,000 units at $136.57) (SEC Form 4)

    4 - CLOROX CO /DE/ (0000021076) (Issuer)

    5/9/25 4:25:25 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Financials

    Live finance-specific insights

    View All

    Clorox Declares Regular Quarterly Dividend of $1.24 Per Share

    OAKLAND, Calif., Feb. 24, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) announced today that its board of directors has declared a quarterly dividend of $1.24 per share on the company's common stock. The dividend is payable May 8, 2026, to shareholders of record as of the close of business on April 22, 2026.Clorox has a long history of providing value to its shareholders through regular dividend payments and annual dividend increases.About The Clorox CompanyThe Clorox Company (NYSE:CLX) champions people to be well and thrive every single day. Headquartered in Oakland, California since 1913, Clorox integrates sustainability into how it does business. Driven by consumer-centric innovation

    2/24/26 8:06:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Reports Q2 Fiscal Year 2026 Results, Confirms Outlook

    OAKLAND, Calif., Feb. 3, 2026 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the second quarter of fiscal year 2026, which ended December 31, 2025. Second-Quarter Fiscal Year 2026 Summary Following is a summary of key results for the second quarter. All comparisons are with the second quarter of fiscal year 2025 unless otherwise stated. Net sales decreased 1% to $1.67 billion, primarily driven by lower consumption and partially offset by shipments ahead of consumption for several businesses. Organic sales1 decreased 1%.Gross margin decreased 60 basis points to 43.2% from 43.8% in the year-ago quarter, primarily driven by higher manufacturing and logistics costs, par

    2/3/26 4:10:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    Clorox Announces Acquisition of GOJO Industries, Makers of Purell®, Market Leader in Skin Health and Hygiene

    Expands Clorox's position in health and hygiene to include skin hygiene Clorox's scale, innovation and distribution capabilities poised to accelerate consumer growth for the Purell brand while GOJO's B2B reach and capabilities bolster Clorox's professional business Acquisition is growth accretive and advances IGNITE strategy; further evolving Clorox's portfolio to strengthen its ability to deliver more consistent, profitable growth OAKLAND, Calif., Jan. 22, 2026  The Clorox Company (NYSE:CLX) today announced that it has entered into a definitive agreement to acquire GOJO Indu

    1/22/26 4:05:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Leadership Updates

    Live Leadership Updates

    View All

    Clorox Announces Appointment of Julia Denman and Stephanie Plaines to its Board of Directors

    OAKLAND, Calif., May 18, 2022 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced the appointment of Julia (Charter) Denman and Stephanie Plaines to its board of directors, bringing additional deep financial expertise and industry leadership experience. Denman, 51, brings nearly 30 years of leadership and financial experience in both the technology and consumer packaged goods sectors. As corporate vice president and head of internal audit, enterprise risk and compliance at Microsoft, she provides independent and objective assessments of the company's business strateg

    5/18/22 4:30:00 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    $CLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Clorox Company (Amendment)

    SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

    2/13/24 5:02:29 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13G/A filed by Clorox Company (Amendment)

    SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

    2/9/23 11:15:26 AM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary

    SEC Form SC 13G/A filed by Clorox Company (Amendment)

    SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

    2/9/22 3:43:30 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary